留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x 关闭 永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

硬膜外舒芬太尼对利多卡因最低局麻药镇痛浓度的影响

谢芳华,  宋少波,  张健

downloadPDF
文章导航 > 药学实践与服务  > 2014 >  32(2): 135-137
谢芳华, 宋少波, 张健. 硬膜外舒芬太尼对利多卡因最低局麻药镇痛浓度的影响[J]. 药学实践与服务, 2014, 32(2): 135-137. doi: 10.3969/j.issn.1006-0111.2014.02.016
引用本文: 谢芳华, 宋少波, 张健. 硬膜外舒芬太尼对利多卡因最低局麻药镇痛浓度的影响[J]. 药学实践与服务, 2014, 32(2): 135-137. doi: 10.3969/j.issn.1006-0111.2014.02.016
shu
XIE Fanghua, SONG Shaobo, ZHANG Jian. The effect of sufentanil on the minimum local analgesic concentration of epidural lidocaine[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(2): 135-137. doi: 10.3969/j.issn.1006-0111.2014.02.016
Citation: XIE Fanghua, SONG Shaobo, ZHANG Jian. The effect of sufentanil on the minimum local analgesic concentration of epidural lidocaine[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(2): 135-137. doi: 10.3969/j.issn.1006-0111.2014.02.016
shu

硬膜外舒芬太尼对利多卡因最低局麻药镇痛浓度的影响

doi: 10.3969/j.issn.1006-0111.2014.02.016
  • 1.

    萧山医院麻醉科, 浙江 萧山 311202

  • 2.

    浙江大学附属第一医院麻醉科, 浙江 杭州 310003

The effect of sufentanil on the minimum local analgesic concentration of epidural lidocaine

  • 1.

    Department of Anesthesiology, Xiaoshan Hospital of Zhejiang Province, Xiaoshan 311202, China

  • 2.

    Department of Anesthesiology, First Affiliated Hospital of Zhejiang University, Hangzhou 310003, China

  • 摘要: 目的 比较不同剂量舒芬太尼对成人腰段硬膜外利多卡因最低局麻药镇痛浓度(MLAC)的影响。 方法 选择择期行泌尿科及肛肠科手术患者90例,ASA Ⅰ级或Ⅱ级,年龄32~63岁,随机分为3组(n=30):L组(单纯利多卡因)、LSF1组(利多卡因＋10 μg舒芬太尼)、LSF2组(利多卡因＋20 μg舒芬太尼)。首例均用1%利多卡因20 ml,其后根据前一例患者的VAS评分,按照序贯增减法依次变动利多卡因的浓度,浓度变化梯度0.1%,观察30 min后痛觉阻滞的程度(VAS≤1为有效),下肢运动阻滞的Bromage分级。根据Dixon和Massey法计算3组利多卡因的MLAC及95%可信区间(CI)。 结果 LSF1组利多卡因用于成年人腰段硬膜外的MLAC为0.590%(95%CI为0.537%~0.660%),LSF2组的MLAC为0.382%(95%CI为0.329%~0.446%),均显著低于L组的MLAC 0.781%(95%CI为0.728%~0.844%)(P<0.01)。在镇痛有效的病例中,LSF2组Bromage分级显著低于L组和LSF1组。 结论 硬膜外利多卡因复合10及20 μg舒芬太尼均能显著减少利多卡因的最低局麻药镇痛浓度,且无明显不良反应,硬膜外利多卡因复合20 μg舒芬太尼在达到同等镇痛效果时,还能显著减轻下肢运动神经的阻滞。20 μg舒芬太尼可能是最佳的复合剂量。
    Abstract: Objective To compare the effect of different dosage of sulfentanil on the minimum local analgesic concentration of epidural licocaine. Methods 90 patients with urology and anorectic surgery, ASA Ⅰ or Ⅱ, 32-63 years, were randomly divided into 3 groups (n=30):L group (only lidocaine), LSF1 group (lidocaine +10 μg sufentanil) and LSF2 group (lidocaine +20 μg sufentanil). First case of patient in each group was given 20 ml of 1% lidocaine, thereafter in accordance with VAS score of the patient, the lidocaine was given by in turn decrease method according to the sequential changes in the concentration of lidocaine. The concentration gradient was 0.1%, and block pain degree was observed after 30 minutes (VAS ≤ 1 is valid), lower limb motor block Bromage classification was observed. MLAC and 95% confidence intervals(CI) of lidocaine in 3 groups was calculated according to Dixon and Massey. Results MLAC of lidocaine on adult lumbar epidural in LSF1 group was 0.590% (95%CI 0.537%-0.660%), MLAC in LSF2 group was 0.382% (95%CI 0.329%-0.446%), and MLAC of both groups were significantly lower than L group 0.781% (95%CI 0.728%-0.844%) (P<0.01). In effective analgesia cases, Bromage grade of LSF2 group was significantly lower than that of L and LSF1 group. Conclusion Epidural lidocaine combined with 10 and 20 μg sufentanil could significantly reduce local anesthetic effect of the minimum analgesic concentration of lidocaine, and no significant adverse reactions. Epidural lidocaine combined with 20 μg sufentanil reached the same analgesic effect, and significantly reduce the lower extremity motor nerve block. So 20 μg sufentanil might be the best combined dose.
  • [1] Dixon WJ, Massey FJ. Introduction to statistical analysis[M]. 4th ed. New York:McGraw-Hill, 1983:428-439.
    [2] Columb MO, Lyons G. Determination of the minimum local analgesic concentrations of epidural bupivacaine and lidocaine in labor[J]. Anesth Analg, 1995, 81:833-837.
    [3] Frawley G, Smith KR, Ingelmo P. Relative potencies of bupivacaine, levobupivacaine, and ropivacaine for neonatal spinal anaesthesia[J]. Br J Anaesth, 2009, 103(5):731-738.
    [4] Boulier V, Gomis P, Lautner C, et al. Minimum local analgesic concentrations of ropivacaine and levobupivacaine with sufentanil for epidural analgesia in labour[J]. Int J Obstet Anesth, 2009, 18(3):226-230.
    [5] Aveline C, Metaoua S, Masmoudi, A, et al. The effect of clonidine on the minimum local analgesic concentration of epidural ropivacaine during labor[J]. Anesth Analg, 2002, 95(3):735-740.
    [6] Panni MK, Columb MO. Obese parturients have lower epidural local anaesthetic requirements for analgesia in labour[J]. Br J Anaesth, 2006, 96(1):106-110.
    [7] Dewandre PY, Kirsch M, Bonhomme V, et al. Impact of the addition of sufentanil 5 microgram or clonidine 75 microgram on the minimum local analgesic concentration of ropivacaine for epidural analgesia in labour:a randomized comparison[J]. Int J Obstet Anesth,2008,17(4):315-321.
    [8] Dewandre PY, Decurninge V, Bonhomme V, et al. Side effects of the addition of clonidine 75 microgram or sufentanil 5 microgram to 0.2% ropivacaine for labour epidural analgesia[J]. Int J Obstet Anesth, 2010, 19(2):149-154.
    [9] Boulier V,Gomis P,Lautner C, et al. Minimum local analgesic concentrations of ropivacaine and levobupivacaine with sufentanil for epidural analgesia in labour[J]. Int J Obstet Anesth, 2009, 18(3):226-309.
    [10] Fraser HM, Chapman V, Dickenson AH. Spinal local anaesthetic actions on afferent evoked responses and wind-up of nociceptive neurones in the rat spinal cord:combination with morphine produces marked potentiation of antinociception[J]. Pain, 1992, 49:33-41.
    [11] Wang C, Chakrabarti MK, Whitwam JG. Specific enhancement by fentanyl of the effects of intrathecal bupivacaine on nociceptive afferent but not on sympathetic efferent pathways in dogs[J]. Anesthesiology, 1993, 79:766-773.
  • [1] 桂明珠, 李静, 李志玲.  儿童伏立康唑的血药浓度与CYP2C19、CYP2C9和CYP3A5基因多态性的相关性研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402020
    [2] 郭灵怡, 刘艳超, 高路, 刘瑞瑶, 吕权真, 俞媛.  醋酸卡泊芬净单硬脂酸甘油酯纳米粒抗白色念珠菌感染的增效作用研究 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202310043
    [3] 王鹏, 陈顺, 赵逸, 高守红, 王志鹏.  卡培他滨致小鼠手足综合征模型的建立及评价 . 药学实践与服务, 2024, 42(9): 385-388, 398. doi: 10.12206/j.issn.2097-2024.202308045
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  2875
  • HTML全文浏览量:  273
  • PDF下载量:  70
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-05-31
  • 修回日期:  2013-12-11

硬膜外舒芬太尼对利多卡因最低局麻药镇痛浓度的影响

doi: 10.3969/j.issn.1006-0111.2014.02.016
  • 1. 萧山医院麻醉科, 浙江 萧山 311202
  • 2. 浙江大学附属第一医院麻醉科, 浙江 杭州 310003
  • 收稿日期: 2013-05-31
  • 修回日期: 2013-12-11

摘要: 目的 比较不同剂量舒芬太尼对成人腰段硬膜外利多卡因最低局麻药镇痛浓度(MLAC)的影响。 方法 选择择期行泌尿科及肛肠科手术患者90例,ASA Ⅰ级或Ⅱ级,年龄32~63岁,随机分为3组(n=30):L组(单纯利多卡因)、LSF1组(利多卡因＋10 μg舒芬太尼)、LSF2组(利多卡因＋20 μg舒芬太尼)。首例均用1%利多卡因20 ml,其后根据前一例患者的VAS评分,按照序贯增减法依次变动利多卡因的浓度,浓度变化梯度0.1%,观察30 min后痛觉阻滞的程度(VAS≤1为有效),下肢运动阻滞的Bromage分级。根据Dixon和Massey法计算3组利多卡因的MLAC及95%可信区间(CI)。 结果 LSF1组利多卡因用于成年人腰段硬膜外的MLAC为0.590%(95%CI为0.537%~0.660%),LSF2组的MLAC为0.382%(95%CI为0.329%~0.446%),均显著低于L组的MLAC 0.781%(95%CI为0.728%~0.844%)(P<0.01)。在镇痛有效的病例中,LSF2组Bromage分级显著低于L组和LSF1组。 结论 硬膜外利多卡因复合10及20 μg舒芬太尼均能显著减少利多卡因的最低局麻药镇痛浓度,且无明显不良反应,硬膜外利多卡因复合20 μg舒芬太尼在达到同等镇痛效果时,还能显著减轻下肢运动神经的阻滞。20 μg舒芬太尼可能是最佳的复合剂量。

English Abstract

谢芳华, 宋少波, 张健. 硬膜外舒芬太尼对利多卡因最低局麻药镇痛浓度的影响[J]. 药学实践与服务, 2014, 32(2): 135-137. doi: 10.3969/j.issn.1006-0111.2014.02.016
引用本文: 谢芳华, 宋少波, 张健. 硬膜外舒芬太尼对利多卡因最低局麻药镇痛浓度的影响[J]. 药学实践与服务, 2014, 32(2): 135-137. doi: 10.3969/j.issn.1006-0111.2014.02.016
shu
XIE Fanghua, SONG Shaobo, ZHANG Jian. The effect of sufentanil on the minimum local analgesic concentration of epidural lidocaine[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(2): 135-137. doi: 10.3969/j.issn.1006-0111.2014.02.016
Citation: XIE Fanghua, SONG Shaobo, ZHANG Jian. The effect of sufentanil on the minimum local analgesic concentration of epidural lidocaine[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(2): 135-137. doi: 10.3969/j.issn.1006-0111.2014.02.016
shu

    全文HTML

参考文献 (11)

目录

    /

    返回文章
    返回

    版权所有：《药学实践与服务》编辑委员会

    主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

    电话: （021）81871324,81871397 E-mail: [email protected]

    网站备案号 沪ICP备05003363号-1

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计